Athos Capital’s Core Scientific CORZ Stock Holding History

Athos Capital’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,221	Closed	-$76K	–	38
2025 Q3	$76K	Buy	+4,221	New	+$61.9K	0.05%	28

Other funds holding CORZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Athos Capital's CORZ Position: Q4 2025 in Review

Athos Capital sold out of Core Scientific (CORZ) in Q4 2025, closing a stake of 4,221 shares — an estimated $76K sold.

Athos Capital first reported a position in CORZ in Q3 2025 and held it in 1 quarter. The position peaked at $76K in Q3 2025. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

Athos Capital reported no remaining Core Scientific position as of Q4 2025 after selling out during the quarter.
Athos Capital sold 4,221 Core Scientific shares in Q4 2025, an estimated $76K.
Athos Capital first reported a position in Core Scientific in Q3 2025 and held it in 1 quarter.
Athos Capital's Core Scientific position peaked at $76K in Q3 2025.
367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on Athos Capital's 13F filing for Q4 2025, filed 12 Feb 2026.